1. Labindia Instruments
Labindia Instruments, promoted by a group of engineers and professionals, is a successful sales, service and support organization. The company is primarily engaged in providing comprehensive solutions for the life science community. Labindia is the exclusive partner in India for Applied Biosystems, responsible for the sales, service and support for their entire range of products. Besides Applied Biosystems, Labindia Group is also dealing with Leica and supporting their microscopy, microtomy and histopathalogy products.
While the company’s total turnover in 2004-05 was Rs 164 crore, the biotech business turnover for the same was Rs 119 crore, up from Rs 67.5 crore the previous year, registering a phenomenal 76 percent growth in their biotech revenues. The company has established a full fledged Application support Laboratory at its Gurgaon site. The Laboratory has latest technologies like, Fast PCR, Real Time PCR, Automated DNA Sequencer, Low density Array, Full Genome Micro-Array in the Molecular Biology Laboratory and Maldi-tof, Hybrid LCMSMS with Linear Ion Trap (4000 QTRAP) in Proteomics and Small molecule laboratory.
2.Waters India
The company offers a comprehensive range of analytical systems across four critical areas: instruments, column chemistries, software and support services. Nearly 70 percent of the company’s revenue is derived from the life science market, a market comprised of drug discovery, drug development, quality control, and the emerging sciences of genomics and proteomics. Most of these clients operate under rigorous regulatory standards set by the US

FDA and other regulatory bodies. Waters business in India last year was $32 m. It registered a growth of 77 percent in 2004-2005 as compared with 64 percent the previous year. Some of the new products it introduced recently are ACQUITY Ultra Performance LC systems, Protein Expression System and QuattroMicro XE quadrupole tandem mass spectrometers. Waters products are also sold into the food and beverage, environmental, fine chemical, personal care product, university, government, semiconductor and plastics markets sectors.
3. Spinco Biotech
Spinco Biotech promotes Affymetrix, USA for GeneChip system – the Gold Standard for Microarray. GeneChip, the most advanced platform reduces the time and cost of discovery research. The company has complete solution for drug discovery from synthesis to purification to evaporation to screening. It represents Multiple Organic Synsthesizers of AAPPTEC (formerly called Advanced Chem Tech), USA and Initiator – Microwave Synthesis from Biotage AB, Sweden for synthesis, Flash Chromatography from Biotage, for purification and high throughput solvent evaporation system from Genevac, UK for evaporation. The company recorded a turnover of Rs 111.5 crore registering a growth of 21 percent.
4. Becton Dickinson India
US-based Becton, Dickinson and Company (BD) operates in India through its wholly owned subsidiary, BD India. The company’s worldwide operations consist of three segments: BD Biosciences, BD Medical and BD Diagnostics. While the company’s total turnover was Rs 209.88 crore in the fiscal year 2004-05, the biotech business turnover for the same fiscal was Rs 106.40 crore, up from Rs 73.82 crore the previous year, registering a 44 percent increase in its biotech business.
Its biosciences segment provides integrated systems, products and services for a variety of applications in life sciences. The major products are flow cytometry systems for cell analysis, monoclonal antibodies for biomedical research, molecular biology reagents for the study of genes, cell growth and screening products and labware products.

The company is a prominent player in immunology and cell analysis sector. BD Biosciences – Immunocytometry systems provides flow cytometry solutions for research and clinical use with applications for immune function, vaccine research, infectious disease, and oncology. In India, BD has supplied nearly 200 flow cytometry systems and has a nearly 90-95 percent market share in flow cytometry solutions. BD is considered a long-term partner of choice for AIDS monitoring and cancer management. This is evident form the fact that nearly 100 percent of AIDs monitoring is done by National AIDS Control Organization (NACO) on BD systems. The company has an efficient support staff consisting of scientific advisors, application scientists, and engineers for value added services to its customers. It has offices in Bangalore, Calcutta, Mumbai, Delhi and Gurgoan.QuattroMicro XE
5.Thermo Electron LLS India Pvt Ltd
Thermo Electron Life and Laboratory Sciences (LLS) India Pvt Ltd, a wholly owned subsidiary of the US-based Thermo Electron Corporation, is a key supplier of advanced analytical technologies, scientific and laboratory equipments and laboratory consumables helping scientists and clinicians discover new drugs, understand its genetic make-up and diagnose illnesses and diseases.
Serving customers from the Middle East, South Asia and Africa region, it has set up a manufacturing unit at Navi Mumbai that produces a range of finn pipette for ELISA readers and washers both for home and export consumption. More than 60 percent of the products manufactured by Thermo Electron LLS India are exported. It currently looks after the life and laboratory science group in the India and bioscience technology division of the life and laboratory science group in South Asia, Middle East and African countries. Its clients base include most of the government sponsored research institutions and private sector research organizations, biological institutions, hospitals, R&D wings of the pharmaceutical companies.Thermo India has a factory and head office in Navi Mumbai and branch offices in Hyderabad, Chennai and New Delhi and engineers based at Kolkata apart from the above offices. Its total sales during the year stood at $20 million (about Rs 86.4 crore) as against last year’s sales of $15.76 million (about Rs 70.92 crore). The sales revenue includes $5.5 million from laboratory equipments division and $14.5 million from

the scientific instruments division. It is expanding its operations this year and moving to a new office that will have a complete team of various divisions of its life and laboratory science sector.
6. Agilent Technologies India (LSCA)
Agilent Technologies Life Sciences and Chemical Analysis (LSCA) group is a leading global provider of instruments, supplies, software and services to life science and chemical analysis markets. The group offers new and futuristic technology solutions and its ability to integrate core technologies in molecular biology, nanotechnology and semiconductors with information sciences software and genetic engineering, biotechnology has led to significant innovations.
In 2004, Agilent LSCA India operations experienced a high double-digit growth and is now LSCA’s fourth largest country of business in Asia. Known as one of the industry leaders in compliance services for the pharmaceutical companies in India, Agilent LSCA continues to expand its presence in the life sciences industries, with its recent introduction of the DNA microarray-based genomics solution in April this year. The revenue for LSCA India is estimated to be about Rs 102 crore in 2004, while according to industry estimates the life sciences revenue accounts for about 70 percent of its turnover. There has been nearly 57 percent growth in its biotech business as compared to that in 2003-04. The global revenue for Agilent LSCA is $1.3 billion in 2004. As Agilent LSCA India strives to provide more innovative solutions for its customers, it will continue to introduce new technologies for biotechnology research as well as next-generation products that address automating the entire scientific workflow to improve productivity and efficiency. In India, Agilent introduced the innovative concept of online technical help for its customers about two and a half years ago, which is a key differentiator.
7. Millipore (India) Pvt Ltd
Millipore (India) Pvt Ltd, a joint venture company with Millipore Corp., has been operational in the country since 1988. It provides technologies, tools and services for the development and production of new therapeutic drugs and serves the life science research, biotechnology and pharmaceutical industries.

It serves the biosciences market, defined as research and manufacturing within the areas of genomics, proteomics, drug discovery, biotechnology and pharmaceuticals. Several thousand devices, products and systems serve the 500,000 laboratories around the world, as well as the 2,500 major biotechnology, pharmaceutical and contract manufacturing companies.
Millipore also offers custom-engineered purification systems that are built and configured to fit within a manufacturing process for pharmaceuticals and biopharmaceuticals. In addition, it provides consulting and customer support services for high-value applications. Millipore Corp. has assigned several new initiatives in the areas of manufacturing and research to Millipore India which would be operationally ready by the end of 2006.The company’s turnover in 2004-2005 was Rs 70.70 crore as against Rs 57.18 crore in 2003-2004, registering a growth of 23 percent.
8. Wipro BioMed
The BioMed division has three verticals – the Life Sciences group (LSG), Diagnostics Sciences Group (DSG) and Medical Sciences Group (MSG). The Life Sciences Group offers R&D equipments and reagents in the proteomics, genomics, and cell lab arena. Beckman Coulter, which provides attractive and comprehensive solutions in these areas, is promoted and supported by Wipro on an exclusive basis in India. Its product range includes DNA sequencer, SNP stream instrument, 2D chromato-focusing system, flow cytometry, etc. Besides Beckman, Wipro has a marketing alliance with Promega, Spotfire, Alfawasermann, Fuginon, Adaltis, Aesculap and Schwind among others.
The biotech business income of Wipro BioMed for the fiscal year 2004-05 was Rs 61.8 crore, up from Rs 52.1 crore the previous year, registering 18.5 percent growth. During the current fiscal, it aims to clock an impressive turnover of about Rs 105 crore. Its entire biotech revenue is generated through agency operations.
9. GE Healthcare
GE Healthcare is a $14 billion unit of General Electric Company (NYSE: GE) that is headquartered in the United Kingdom. Worldwide, GE Healthcare employs more than

42,500 people to serve healthcare professionals and their patients in more than 100 countries. GE Healthcare Technologies is an $11 billion business of GE Healthcare that provides a broad portfolio of medical imaging and information technologies, patient monitoring systems and healthcare services.
GE Healthcare Bio-Sciences is a $3 billion business of GE Healthcare that provides medical diagnostics, drug discovery and protein separation systems. Its diagnostic imaging agents are used during medical scanning procedures to highlight organs, tissues and cells inside the human body, for the early detection, diagnosis and management of disease.GE Healthcare’s turnover was Rs 54.30 crore in 2004-05 as compared to Rs 41 crore the previous year, registering a 32 percent growth.
10. Alfa Laval India Ltd
Alfa Laval India, a sales company for Alfa Laval Group of Sweden, manufactures and supplies a wide range of key components and systems in separation, heat transfer and flow technology to life sciences companies. In 1987, it became Alfa Laval India Ltd and subsequently a holding company of Alfa Laval AB Corporates, Sweden with which it has a technical collaboration. It is a key supplier of centrifugal separators and decanters and flow equipment.
The company manufactures and supplies a wide range of key components and systems for food, chemical, biotechnology and pharmaceutical industries at its plant in Pune. It has launched many products such as automation system PharmaX and PharmaLine heat exchangers, BTPX and LAPX separators, membrane filtration technology and solid pump. Considering the growth and importance of fuel ethanol it is looking at developing technology for biodiesel. It started its business in life sciences with Biocon India as its first client. It had sales of Rs 46 crore from the life sciences division, an increase of Rs 6 crore over last year. This is mainly because it had received a major order from Biocon, a leading biotechnology company in the country..

Regards